Related Experiment Video
Updated: Feb 15, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP
1Division of Endocrinology, Diabetes, and Metabolism, Comprehensive Diabetes Center and Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Purpose Of Review:
Thioredoxin-interacting protein has emerged as a major factor regulating pancreatic β-cell dysfunction and death, key processes in the pathogenesis of type 1 and type 2 diabetes. Accumulating evidence based on basic, preclinical, and retrospective epidemiological research suggests that TXNIP represents a promising therapeutic target for diabetes. The present review is aimed at providing an update regarding these developments.
Recent Findings:
TXNIP has been shown to be induced by glucose and increased in diabetes and to promote β-cell apoptosis, whereas TXNIP deletion protected against diabetes. More recently, TXNIP inhibition has also been found to promote insulin production and glucagon-like peptide 1 signaling via regulation of a microRNA. β-Cell TXNIP expression itself was found to be regulated by hypoglycemic agents, carbohydrate-response-element-binding protein, and cytosolic calcium or the calcium channel blocker, verapamil. Retrospective studies now further suggest that verapamil use might be associated with a lower incidence of type 2 diabetes in humans.
Summary:
TXNIP has emerged as a key factor in the regulation of functional β-cell mass and TXNIP inhibition has shown beneficial effects in a variety of studies. Thus, the inhibition of TXNIP may provide a novel approach to the treatment of diabetes.
Insights
Thioredoxin-interacting protein (TXNIP) drives pancreatic beta-cell dysfunction in diabetes. Inhibiting TXNIP shows promise for novel diabetes treatments by protecting beta-cells and enhancing insulin signaling.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Molecular Biology
Background:
- Thioredoxin-interacting protein (TXNIP) is a key regulator of pancreatic beta-cell function and survival.
- Dysregulation of TXNIP is implicated in the pathogenesis of type 1 and type 2 diabetes.
- TXNIP's role in beta-cell apoptosis makes it a potential therapeutic target.
Purpose of the Study:
- To review recent developments regarding TXNIP as a therapeutic target for diabetes.
- To update on the role of TXNIP in beta-cell dysfunction and death.
- To explore novel treatment strategies targeting TXNIP.
Main Methods:
- Review of basic, preclinical, and epidemiological research.
- Analysis of studies on TXNIP induction by glucose and its role in diabetes.
- Examination of TXNIP regulation by microRNAs, hypoglycemic agents, and calcium signaling.
Main Results:
- TXNIP is induced by glucose and increased in diabetes, promoting beta-cell apoptosis.
- TXNIP deletion protects against diabetes; TXNIP inhibition enhances insulin production and GLP-1 signaling.
- TXNIP expression is modulated by hypoglycemic agents, ChREBP, and calcium signaling (e.g., verapamil).
- Retrospective studies suggest verapamil use may correlate with lower type 2 diabetes incidence.
Conclusions:
- TXNIP is a critical factor in regulating functional beta-cell mass.
- TXNIP inhibition demonstrates beneficial effects in various studies.
- Targeting TXNIP offers a novel therapeutic approach for diabetes treatment.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
Standard Electrode Potentials
Gene Therapy
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...

